Three Children Died of Acute Hepatitis in Indonesia Last Month
(Bloomberg) -- Three pediatric patients in Indonesia died from acute hepatitis in April, the country's health ministry said, boosting the global death toll from the mysterious liver ailment affecting children from the U.S. to Asia to at least four.
The children, hospitalized in the capital Jakarta, had symptoms including nausea, vomiting, heavy diarrhea, fever, jaundice, seizures and loss of consciousness, the ministry said in a statement Monday. It is urging parents to immediately bring children who exhibit these symptoms to the hospital.Â
The ministry is running a full panel of tests to determine the cause of the disease and has issued a circular to step up nationwide surveillance for the illness, it said.
Over the weekend, Singapore confirmed a case of acute hepatitis in a 10-month old baby and is investigating whether it has a similar presentation to other cases reported worldwide.
Read more: What's the Mysterious Liver Disease Making Kids Sick?
At least one other child has died from acute hepatitis, and more than a dozen others globally have undergone liver transplants after coming down with the disease, according to the World Health Organization. While the cause of the sickness is yet to be determined, investigators are studying a family of pathogens called adenoviruses that cause a range of illnesses including the common cold.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.